We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BHC.TO

Price
7.99
Stock movement down
-0.77 (-8.79%)
Company name
Bausch Health Companies Inc
Exchange
(TO
,
Currency
CAD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
2.94B
Ent value
29.00B
Price/Sales
0.31
Price/Book
-
Div yield
5.02%
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
1.87
PEG
-
EPS growth
-32.83%
1 year return
-41.25%
3 year return
-34.87%
5 year return
-18.12%
10 year return
-29.42%
Last updated: 2025-04-04

DIVIDENDS

Dividend yield - 5y

Dividend yield data
Dividend per share0.40
Dividend yield5.02%
Payout frequency-
Maximum yield7.29%
Average yield2.86%
Minimum yield0.93%
Discount to avg yield43.06%
Upside potential75.61%
Yield as % of max yield68.84%

Yield distribution (inverse percentile) - 5y

Yield distribution data
Dividend yield5.02%
Current yield distribution3.49%
Yield at 100% (Min)0.93%
Yield at 90%1.12%
Yield at 80%1.27%
Yield at 50% (Median)3.36%
Yield at 20%4.09%
Yield at 10%4.40%
Yield at 0% (Max)7.29%

Dividend per share

Dividend per share data
Years of growth-
CCC status-
Dividend per share0.40
Payout frequency-
Ex-div date10 Nov 2010
EPS (TTM)-0.48
EPS (1y forward)4.28
EPS growth (5y)-32.83%
EPS growth (5y forward)-

Dividend growth

Please create a free account or log in to access this chart
Dividend growth data
BHC.TOS&P500
DGR MR0.91%-13.74%
DGR TTM-66.30%6.60%
DGR 3 years11.52%5.24%
DGR 5 years-5.40%
DGR 10 years-7.07%
DGR 15 years-6.12%
Time since last change announced-
EPS growth (5y)-32.83%
EPS growth (5y forward)-

Payout ratio

Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM--
Average--
Forward9.38%-

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF2.12
Price to FCF2.91
Price to EBITDA2.12
EV to EBITDA20.89

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales0.31
Price to Book-
EV to Sales3.06

FINANCIALS

Per share

Per share data
Current share count367.80M
EPS (TTM)-0.48
FCF per share (TTM)2.74

Income statement

Income statement data
Revenue (TTM)9.47B
Gross profit (TTM)6.71B
Operating income (TTM)1.35B
Net income (TTM)-178.00M
EPS (TTM)-0.48
EPS (1y forward)4.28

Margins

Margins data
Gross margin (TTM)70.87%
Operating margin (TTM)14.25%
Profit margin (TTM)-1.88%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash719.00M
Net receivables2.09B
Total current assets5.35B
Goodwill11.17B
Intangible assets5.65B
Property, plant and equipment0.00
Total assets26.54B
Accounts payable667.00M
Short/Current long term debt21.51B
Total current liabilities4.51B
Total liabilities26.78B
Shareholder's equity-242.00M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.39B
Capital expenditures (TTM)377.00M
Free cash flow (TTM)1.01B
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-0.67%
Return on Invested Capital-84.36%
Cash Return on Invested Capital478.20%

STOCK INFORMATION

Stock chart

Stock price data
Open8.53
Daily high8.60
Daily low7.96
Daily Volume373K
All-time high346.32
1y analyst estimate8.18
Beta0.74
EPS (TTM)-0.48
Dividend per share0.40
Ex-div date10 Nov 2010
Next earnings date30 Apr 2025

Downside potential

Downside potential data
BHC.TOS&P500
Current price drop from All-time high-97.69%-12.44%
Highest price drop-98.41%-56.47%
Date of highest drop28 Jul 20229 Mar 2009
Avg drop from high-56.38%-11.07%
Avg time to new high31 days12 days
Max time to new high2868 days1805 days
COMPANY DETAILS
BHC.TO (Bausch Health Companies Inc) company logo
Marketcap
2.94B
Marketcap category
Mid-cap
Description
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Employees
20270
Website
https://www.bauschhealth.com
Investor relations
-
SEC filings
BHC.TO SEC filings
CEO
Country
Canada
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved